Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
BJU International
|
November 9, 2000
Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology Group
M M Elhilali, M Gleave, Y Fradet, et al.
British Journal of Cancer
|
January 1, 1995
Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer
V Ravery, M Colombel, Z Popov, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1984
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies
Y Fradet, C Cordon-Cardo, T Thomson, et al.
Cytometry
|
January 1, 1991
DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells
L L Wheeless, J E Reeder, M J O'Connell, et al.
Cancer Research
|
June 1, 1992
Antibody drug carrier for immunotherapy of superficial bladder cancer: ultrastructural studies
E de Harven, Y Fradet, J G Connolly, et al.
The Journal of Urology
|
December 1, 1991
Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder
E Huland, H Huland, T Meier, et al.
The New England Journal of Medicine
|
May 1, 1998
Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group
M E Gleave, M Elhilali, Y Fradet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2000
Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network
L M McShane, R Aamodt, C Cordon-Cardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 1998
Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network
P Lianes, E Charytonowicz, C Cordon-Cardo, et al.
Cancer Research
|
October 1, 1985
Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder
J L Huffman, Y Fradet, C Cordon-Cardo, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
BJU International
|
November 9, 2000
Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology Group
M M Elhilali, M Gleave, Y Fradet, et al.
British Journal of Cancer
|
January 1, 1995
Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer
V Ravery, M Colombel, Z Popov, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1984
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies
Y Fradet, C Cordon-Cardo, T Thomson, et al.
Cytometry
|
January 1, 1991
DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells
L L Wheeless, J E Reeder, M J O'Connell, et al.
Cancer Research
|
June 1, 1992
Antibody drug carrier for immunotherapy of superficial bladder cancer: ultrastructural studies
E de Harven, Y Fradet, J G Connolly, et al.
The Journal of Urology
|
December 1, 1991
Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder
E Huland, H Huland, T Meier, et al.
The New England Journal of Medicine
|
May 1, 1998
Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group
M E Gleave, M Elhilali, Y Fradet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2000
Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network
L M McShane, R Aamodt, C Cordon-Cardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 1998
Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network
P Lianes, E Charytonowicz, C Cordon-Cardo, et al.
Cancer Research
|
October 1, 1985
Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder
J L Huffman, Y Fradet, C Cordon-Cardo, et al.
Page
of 11